Lipoprotein(a) or Lp(a) is a genetically controlled risk factor for a heart attack. Cardiologist explains why it's important to be aware of your levels.

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

Most health-conscious people closely track their cholesterol, blood sugar, and blood pressure, but cardiologists are now highlighting another vital yet often ignored heart health factor, Lipoprotein(a ...

A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...

NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...

While most health-conscious people diligently monitor their cholesterol, sugar, and blood pressure, cardiologists are now calling attention to another silent player in heart health — Lipoprotein(a) or ...

Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, ...

The evidence implicating high levels of lipoprotein(a), or Lp(a), as a risk predictor for heart attack, stroke, and other cardiovascular conditions has outpaced the science of what to do about the ...

Please provide your email address to receive an email when new articles are posted on . A lipoprotein(a) assay received breakthrough device designation from the FDA. The assay is designed to aid in ...

High concentrations of lipoprotein(a), a molecule in the body used for accelerating wound healing, blood clotting and stimulating growth of new vessels, are associated with an increased risk of heart ...

The results of a recent retrospective analysis of electronic health record (EHR) data found that only 0.4% of patients with atherosclerotic cardiovascular disease (ASCVD) were tested for lipoprotein(a ...

Routine blood tests in the not-too-distant future may feature a new line item: lipoprotein(a). High levels of this fat- and cholesterol-carrying protein increase the risk of cardiovascular disease, ...